
Christopher C. Caillouet
Examiner (ID: 8951, Phone: (571)270-3968 , Office: P/1745 )
| Most Active Art Unit | 1745 |
| Art Unit(s) | 1791, 1745 |
| Total Applications | 862 |
| Issued Applications | 546 |
| Pending Applications | 67 |
| Abandoned Applications | 259 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10685674
[patent_doc_number] => 20160031819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-04
[patent_title] => 'BASE ADDITION SALTS OF NITROXOLINE AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/777185
[patent_app_country] => US
[patent_app_date] => 2014-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13800
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14777185
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/777185 | Base addition salts of nitroxoline and uses thereof | Mar 16, 2014 | Issued |
Array
(
[id] => 10090212
[patent_doc_number] => 09127024
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-08
[patent_title] => 'Boron-containing diacylhydrazines'
[patent_app_type] => utility
[patent_app_number] => 14/212526
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 67006
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14212526
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/212526 | Boron-containing diacylhydrazines | Mar 13, 2014 | Issued |
Array
(
[id] => 9736167
[patent_doc_number] => 20140271878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'CRYSTALS OF LAQUINIMOD SODIUM AND IMPROVED PROCESS FOR THE MANUFACTURE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/214191
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 21504
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14214191
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/214191 | Crystals of laquinimod sodium and improved process for the manufacture thereof | Mar 13, 2014 | Issued |
Array
(
[id] => 10063789
[patent_doc_number] => 09102620
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-11
[patent_title] => 'Deuterated N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/213279
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15363
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14213279
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/213279 | Deuterated N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof | Mar 13, 2014 | Issued |
Array
(
[id] => 10677920
[patent_doc_number] => 20160024065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'COUMARIN DERIVATIVES AND METHODS OF USE IN TREATING CYSTIC FIBROSIS, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AND MISFOLDED PROTEIN DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/775010
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 15127
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14775010
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/775010 | Coumarin derivatives and methods of use in treating cystic fibrosis, chronic obstructive pulmonary disease, and misfolded protein disorders | Mar 13, 2014 | Issued |
Array
(
[id] => 11506188
[patent_doc_number] => 09597330
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-21
[patent_title] => 'Drugs for treating respiratory diseases'
[patent_app_type] => utility
[patent_app_number] => 14/776315
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56529
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776315
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/776315 | Drugs for treating respiratory diseases | Mar 12, 2014 | Issued |
Array
(
[id] => 9719640
[patent_doc_number] => 20140255340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-11
[patent_title] => 'Amorphous (5-Fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-Acetic Acid'
[patent_app_type] => utility
[patent_app_number] => 14/206874
[patent_app_country] => US
[patent_app_date] => 2014-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 19774
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14206874
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/206874 | Amorphous (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid | Mar 11, 2014 | Issued |
Array
(
[id] => 10063843
[patent_doc_number] => 09102674
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-11
[patent_title] => 'Substituted naphthyridine and quinoline compounds as MAO inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/204738
[patent_app_country] => US
[patent_app_date] => 2014-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51747
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14204738
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/204738 | Substituted naphthyridine and quinoline compounds as MAO inhibitors | Mar 10, 2014 | Issued |
Array
(
[id] => 11389498
[patent_doc_number] => 09550732
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-24
[patent_title] => 'Salt of pyrrolidin-3-yl acetic acid derivative and crystals thereof'
[patent_app_type] => utility
[patent_app_number] => 14/768520
[patent_app_country] => US
[patent_app_date] => 2014-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14806
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14768520
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/768520 | Salt of pyrrolidin-3-yl acetic acid derivative and crystals thereof | Mar 9, 2014 | Issued |
Array
(
[id] => 9568567
[patent_doc_number] => 20140186280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'NEUROPROTECTIVE AND NEURO-RESTORATIVE IRON CHELATORS AND MONOAMINE OXIDASE INHIBITORS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/196490
[patent_app_country] => US
[patent_app_date] => 2014-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 27051
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14196490
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/196490 | NEUROPROTECTIVE AND NEURO-RESTORATIVE IRON CHELATORS AND MONOAMINE OXIDASE INHIBITORS AND USES THEREOF | Mar 3, 2014 | Abandoned |
Array
(
[id] => 9561962
[patent_doc_number] => 20140179675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'QUINOLONE COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 14/193656
[patent_app_country] => US
[patent_app_date] => 2014-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 51530
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14193656
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/193656 | Quinolone compound | Feb 27, 2014 | Issued |
Array
(
[id] => 9561962
[patent_doc_number] => 20140179675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'QUINOLONE COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 14/193656
[patent_app_country] => US
[patent_app_date] => 2014-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 51530
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14193656
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/193656 | Quinolone compound | Feb 27, 2014 | Issued |
Array
(
[id] => 10663554
[patent_doc_number] => 20160009698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-14
[patent_title] => 'SALTS OF 2-AMINO-1-HYDROXYETHYL-8-HYDROXYQUINOLIN-2(1H)-ONE DERIVATIVES HAVING BOTH β2 ADRENERGIC RECEPTOR AGONIST AND M3 MUSCARINIC RECEPTOR ANTAGONIST ACTIVITIES'
[patent_app_type] => utility
[patent_app_number] => 14/770206
[patent_app_country] => US
[patent_app_date] => 2014-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 9850
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14770206
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/770206 | Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both β2 adrenergic receptor agonist and M3 muscarinic receptor antagonist activities | Feb 26, 2014 | Issued |
Array
(
[id] => 9686607
[patent_doc_number] => 20140243372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'BENZOIC ACID DERIVATIVE MDM2 INHIBITOR FOR THE TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/192553
[patent_app_country] => US
[patent_app_date] => 2014-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19849
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14192553
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/192553 | Benzoic acid derivative MDM2 inhibitor for the treatment of cancer | Feb 26, 2014 | Issued |
Array
(
[id] => 10663508
[patent_doc_number] => 20160009651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-14
[patent_title] => 'NOVEL COMPOUND, PRODUCTION METHOD THEREFOR, AND USE OF SAID COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 14/770492
[patent_app_country] => US
[patent_app_date] => 2014-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 24110
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14770492
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/770492 | Compound, production method therefor, and use of said compound | Feb 23, 2014 | Issued |
Array
(
[id] => 10864172
[patent_doc_number] => 08889871
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-18
[patent_title] => 'Hepatitis C virus inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/183247
[patent_app_country] => US
[patent_app_date] => 2014-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 165587
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14183247
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/183247 | Hepatitis C virus inhibitors | Feb 17, 2014 | Issued |
Array
(
[id] => 11450270
[patent_doc_number] => 09573902
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-21
[patent_title] => 'Process for the preparation of Ivacaftor and its intermediates'
[patent_app_type] => utility
[patent_app_number] => 14/768082
[patent_app_country] => US
[patent_app_date] => 2014-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7357
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14768082
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/768082 | Process for the preparation of Ivacaftor and its intermediates | Feb 13, 2014 | Issued |
Array
(
[id] => 11737046
[patent_doc_number] => 09701621
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-11
[patent_title] => 'Poly-cyanostilbene macrocycles'
[patent_app_type] => utility
[patent_app_number] => 14/767570
[patent_app_country] => US
[patent_app_date] => 2014-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 5
[patent_no_of_words] => 16796
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14767570
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/767570 | Poly-cyanostilbene macrocycles | Feb 12, 2014 | Issued |
Array
(
[id] => 10483257
[patent_doc_number] => 20150368277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-24
[patent_title] => 'PREPARATION OF ALKALINE EARTH METAL-COMPLEXED METAL BISAMIDES FROM METAL MONOAMIDES'
[patent_app_type] => utility
[patent_app_number] => 14/766160
[patent_app_country] => US
[patent_app_date] => 2014-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6529
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14766160
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/766160 | Preparation of alkaline earth metal-complexed metal bisamides from metal monoamides | Feb 10, 2014 | Issued |
Array
(
[id] => 9817937
[patent_doc_number] => 08927723
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-06
[patent_title] => 'Preparation of pyridonecarboxylic acid antibacterials'
[patent_app_type] => utility
[patent_app_number] => 14/176334
[patent_app_country] => US
[patent_app_date] => 2014-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7714
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14176334
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/176334 | Preparation of pyridonecarboxylic acid antibacterials | Feb 9, 2014 | Issued |